Evolutionary Trajectories and Reservoir Contributions to Viral Rebound Following Suppressive and Genome-Editing Therapies in HIV-1–Infected Humanized Mice

Authors

  • Daniel R. McLeod Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada Author
  • Michael K. Chen Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada Author
  • Sarah J. Thompson Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada Author

DOI:

https://doi.org/10.66525/ijictt68

Keywords:

HIV-1 rebound, viral evolution, humanized mouse model, antiretroviral therapy, CRISPR intervention, viral reservoir

Abstract

Viral rebound following treatment interruption remains a major obstacle to durable HIV-1 remission, even after suppressive antiretroviral therapy or genome-editing interventions. This study examined the evolutionary dynamics and reservoir origins of rebound viruses in HIV-1–infected humanized mice subjected to combination antiretroviral therapy alone or combined with CRISPR-based proviral targeting. Humanized NOD/SCID/IL2Rγ-null mice (n = 50) were infected with HIV-1 and maintained under long-term viral suppression before treatment withdrawal. Plasma rebound viruses were longitudinally sampled over 6 weeks and analyzed using deep sequencing of env, gag, and pol regions. Viral genetic diversity, compartmentalization indices, and selection pressures were quantified and compared with proviral sequences recovered from lymphoid and non-lymphoid tissues prior to treatment interruption. Mice receiving combined therapy exhibited delayed rebound (median 18 vs. 9 days) and reduced peak viremia (2.3 log₁₀ lower, p < 0.01) compared with antiretroviral-only controls. Phylogenetic analyses revealed that rebound viruses originated from a limited subset of pre-existing proviral lineages, with reduced genetic diversity (Shannon index decrease of 41%) in the combined-treatment group. Notably, signatures of positive selection were enriched in envelope regions associated with immune evasion, whereas CRISPR target sites showed no evidence of adaptive escape mutations. These findings indicate that rebound viruses arise from genetically constrained reservoirs shaped by prior therapeutic pressure and highlight the importance of integrating evolutionary analyses when evaluating curative HIV-1 strategies.

Downloads

Download data is not yet available.

References

Villanueva Guzman, M. D. M., Yao, Z., Li, M. M., & Noval, M. G. (2025). Hidden in Plain Sight: Alphavirus Persistence and Its Potential for Driving Chronic Pathogenesis. Viruses, 18(1), 30.

Zhang, C., Li, H., Poluektova, L. Y., Gendelman, H. E., & Dash, P. K. (2025). Unique molecular signatures in rebound viruses from antiretroviral drug and CRISPR-treated HIV-1-infected humanized mice. Communications Biology, 8(1), 1077.

Hendricks, C. M. (2022). Dynamics of HIV Reservoirs During Sequential ATI (Doctoral dissertation, University of Miami).

Wu, Q., Shao, Y., Wang, J., & Sun, X. (2025). Learning Optimal Multimodal Information Bottleneck Representations. arXiv preprint arXiv:2505.19996.

Garcia, M. A., Farrell-Sherman, A., Zhuo, J., Fray, E., Zinsser, A. M., Aydin, B., ... & Siliciano, J. D. (2025). Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir. BioRxiv, 2025-12.

Yang, Y., Guo, M., Corona, E. A., Daniel, B., Leuze, C., & Baik, F. (2025). VR MRI Training for Adolescents: A Comparative Study of Gamified VR, Passive VR, 360 Video, and Traditional Educational Video. arXiv preprint arXiv:2504.09955.

Pardons, M. (2025). Mapping the anatomical distribution and persistence of HIV-infected cell clones in tissues: implications for HIV cure strategies. Current Opinion in HIV and AIDS, 20(6), 519-525.

Banstola, A., & Reynolds, J. N. (2022). The sheep as a large animal model for the investigation and treatment of human disorders. Biology, 11(9), 1251.

Ye, M., Liu, W., Cheng, S., & Yan, L. (2022). Immediate vs conventional loading of mandibular overdentures: A comprehensive systematic review and meta-analysis of randomized controlled trials. Journal of Oral Implantology, 48(1), 64-73.

Satija, N., Patel, F., Schmidt, G., Doanman, D. V., Kapoor, M., La Porte, A., ... & Chen, B. K. (2025). Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model. Nature Communications, 16(1), 2233.

Liu, W., Zhang, W., & Ye, M. (2024). Association between carbohydrate-to-fiber ratio and the risk of periodontitis. Journal of Dental Sciences, 19(1), 246-253.

Kinloch, N. N., Shahid, A., Dong, W., Kirkby, D., Jones, B. R., Beelen, C. J., ... & Brumme, Z. L. (2023). HIV reservoirs are dominated by genetically younger and clonally enriched proviruses. MBio, 14(6), e02417-23.

Sheu, J. B., & Gao, X. Q. (2014). Alliance or no alliance—Bargaining power in competing reverse supply chains. European Journal of Operational Research, 233(2), 313-325.

Mugo Moses, H. The Role of CRISPR-Based Gene Editing in Eradicating Latent HIV Reservoirs in Patients on Antiretroviral Therapy (ART): A Scoping Review.

Yang, Y., Xie, X., Wang, X., Zhang, H., Yu, C., Xiong, X., ... & Baik, F. (2025). Impact of Target and Tool Visualization on Depth Perception and Usability in Optical See-Through AR. arXiv preprint arXiv:2508.18481.

Magro, G., Calistri, A., & Parolin, C. (2022). How to break free: HIV-1 escapes from innovative therapeutic approaches. Frontiers in Virology, 2, 933418.

Ye, M., Liu, W., Cheng, S., & Yan, L. (2023). Efficacy of Adjunctive Chlorhexidine in non-surgical treatment of Peri-Implantitis/Peri-Implant Mucositis: An updated systematic review and meta-analysis. Pakistan journal of medical sciences, 39(2), 595.

Yudaeva, A., Kostyusheva, A., Kachanov, A., Brezgin, S., Ponomareva, N., Parodi, A., ... & Kostyushev, D. (2024). Clinical and translational landscape of viral gene therapies. Cells, 13(22), 1916.

Zheng, Z., Wu, S., & Ding, W. (2025). CTLformer: A Hybrid Denoising Model Combining Convolutional Layers and Self-Attention for Enhanced CT Image Reconstruction. arXiv preprint arXiv:2505.12203.

Shaw, C. L., & Kennedy, D. A. (2025). Early epidemiological characteristics explain the chance of population-level virus persistence following spillover events. PLoS biology, 23(8), e3003315.

Wang, Y., Chen, J., Arias, R., Wang, Y., & Yin, X. (2026). Development and Validation of a Patient-Friendly Digital Assessment Platform for Precision Screening of Oral Anti-Obesity Medications (AOMs).

Ikeogu, N., Ajibola, O., Zayats, R., & Murooka, T. T. (2023). Identifying physiological tissue niches that support the HIV reservoir in T cells. MBio, 14(5), e02053-23.

Wang, Y., Wang, Y., Yin, X., Arias, R., & Chen, J. (2026). Research on Dynamic Assessment of Glucose‐Lipid Metabolism and Personalized Drug Response Prediction Based on Wearable Multimodal Sensing.

Chuprin, J., Buettner, H., Seedhom, M. O., Greiner, D. L., Keck, J. G., Ishikawa, F., ... & Brehm, M. A. (2023). Humanized mouse models for immuno-oncology research. Nature Reviews Clinical Oncology, 20(3), 192-206.

Ahmad, N. R. (2025). Exploring the role of digital technologies in enhancing supply chain efficiency: A case study of e-commerce companies. Indus Journal of Social Sciences, 3(1), 226–237. https://doi.org/10.59075/ijss.v3i1.618

Downloads

Published

2026-03-01